Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

MDS and AML in Shwachman-Diamond Syndrome: Clinical Features and Outcomes

Blood (2017) 130 (Supplement 1): 1177.

https://doi.org/10.1182/blood.V130.Suppl_1.1177.1177

Published: 2017

Journal Articles

Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 2667.

https://doi.org/10.1182/blood.V130.Suppl_1.2667.2667

Published: 2017

Journal Articles

CLL Cell-Derived Exosomes Promote Bone Marrow Fibrosis and Inhibit Normal Hematopoietic Colony Proliferation

Uri Rozovski, MD, David M. Harris, Ping Li, PhD, Zhiming Liu, Taghi Manshouri, Ivo Veletic, MD, Carlos Bueso-Ramos, MD PhD, Preetesh Jain, MBBS,MDDM,PhD, Srdan Verstovsek, MD PhD, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Nitin Jain, MD, William G Wierda, MD PhD, Michael J. Keating, MD, Zeev Estrov, MD

Blood (2017) 130 (Supplement 1): 1728.

https://doi.org/10.1182/blood.V130.Suppl_1.1728.1728

Published: 2017

Journal Articles

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Preetesh Jain, MBBS,MDDM,PhD, Keyur P. Patel, MD PhD, Andrew Futreal, PhD, Curtis Gumbs, Shimin Hu, PhD MD, Carlos Bueso Ramos, MD, Michael Wang, MD, Jorge Romaguera, Luis E. Fayad, MD, Robert Z. Orlowski, PhD, MD, Jeffrey Medeiros, Nathan Fowler, MD

Blood (2015) 126 (23): 2700.

https://doi.org/10.1182/blood.V126.23.2700.2700

Published: 2015

Journal Articles

APcK 110, a novel Inhibitor of Kit, Extends Survival of NOD-SCID Mice in An AML Xenograft Model.

Stefan Faderl, MD, Carlos Bueso-Ramos, MD, PhD, Zhiming Liu, Ashutosh Pal, William Bornmann, PhD, David Harris, Inbal Hazan-Halevy, PhD, Hagop M. Kantarjian, MD, Zeev Estrov, MD

Blood (2009) 114 (22): 1045.

https://doi.org/10.1182/blood.V114.22.1045.1045

Published: 2009

Journal Articles

Cross-Talk Between CLL Cells and Endothelial Cells in the Bone Marrow Microenvironment: Role of Signal Transducer and Activator of Transcription (Stat)-3.

Xavier C. Badoux, MBBS, Carlos Bueso Ramos, MD, PhD, David Harris, B.S., Ping Li, Ph.D., Zhiming Liu, B.S., Jan Burger, M.D., Susan O'Brien, MD, Alessandra Ferrajoli, MD., Michael Keating, MD, Zeev Estrov, MD

Blood (2009) 114 (22): 1242.

https://doi.org/10.1182/blood.V114.22.1242.1242

Published: 2009

Journal Articles

Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia.

Sirisha C Maddipoti, M.D., Carlos Bueso-Ramos, MD, Hui Yang, MD, PhD, Michael Fernandez, Shaoquing Kuang, MD, PhD, Zihong Fang, PhD, William Stevenson, MD, Yue Wei, PhD, Sherry Pierce, RN, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 3341.

https://doi.org/10.1182/blood.V112.11.3341.3341

Published: 2008

Journal Articles

High T-Cell Lymphoma Breakpoint 1 (TCL1) Levels Are Associated with Lack of Response and Inferior Outcome Following Fludarabine, Cyclophosphamide, Rituximab (FCR) Frontline Therapy in Patients with Chronic Lymphocytic Leukemia (CLL).

Ellen Schlette, MD, Constantine S. Tam, MB.BS, Marco Herling, MD, Carlos Bueso-Ramos, MD, PhD, William Wierda, MD, Alessandra Ferrajoli, MD, Susan O’Brien, MD, Michael Keating, MB.BS, Dan Jones

Blood (2008) 112 (11): 2086.

https://doi.org/10.1182/blood.V112.11.2086.2086

Published: 2008

Journal Articles

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Fabio P.S. Santos, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Charles A. Koller, MD, Miloslav Beran, MD, PhD, Gautam Borthakur, MD, Carlos Bueso-Ramos, MD, PhD, Michael Keating, MB, BS, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD

Blood (2008) 112 (11): 925.

https://doi.org/10.1182/blood.V112.11.925.925

Published: 2008

Journal Articles

ZAP-70 Status Does Not Predict Outcome after Nonmyeloablative Allogeneic Stem-Cell Transplantation (NST) in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) That Fails To Respond to Conventional Chemoimmunotherapy.

Issa F. Khouri, MD, Rima M. Saliba, PHD, Joan Admirand, MD, Susan O’Brien, MD, Ming-S. Lee, MD, Barry I. Samuels, MD, Sergio Giralt, MD, Marcos de Lima, MD, Michael J. Keating, MD, Richard E. Champlin, MD, Carlos Bueso-Ramos, MD

Blood (2006) 108 (11): 3028.

https://doi.org/10.1182/blood.V108.11.3028.3028

Published: 2006

Journal Articles

Detection of Residual p73 DNA Methylation Predicts for Shorter Disease Free and Overall Survival in Patients (pts) with Philadelphia (Ph) Chromosome Negative Acute Lymphocytic Leukemia (ALL) in Remission.

Guillermo Garcia-Manero, MD, Carlos Bueso-Ramos, MD, Lianchun Xiao, Koyu Hoshino, MD, Gary Rosner, PhD, Sherry Pierce, RN, Hui Yang, MD, PhD

Blood (2006) 108 (11): 2333.

https://doi.org/10.1182/blood.V108.11.2333.2333

Published: 2006

Journal Articles

A Biologically Distinctive Subgroup of Acute Myelogenous Leukemia with Characteristic Nuclear Morphology and a High Frequency of FLT3 Mutation.

Weina Chen, MD, PhD, George Rassidakis, MD, PhD, Mark Routbort, MD, Dan Jones, MD, PhD, L. Jeffrey Medeiros, MD, Carlos Bueso-Ramos, MD, PhD

Blood (2005) 106 (11): 4522.

https://doi.org/10.1182/blood.V106.11.4522.4522

Published: 2005

Journal Articles

Epstein-Barr Virus in Patients with Chronic Lymphocytic Leukemia.

Apostolia-Maria Tsimberidou, MD, PhD, Michael J. Keating, MD, Carlos Bueso-Ramos, MD, PhD, Razelle Kurzrock, MD, FACP

Blood (2005) 106 (11): 2113.

https://doi.org/10.1182/blood.V106.11.2113.2113

Published: 2005

Journal Articles

Chemo-Immunotherapy with Hyper-CVAD Plus Ritixumab for Adult Burkitt’s and Burkitt’s Type Lymphoma (BL) or Acute Lymphoblastic Leukemia (B-ALL).

Deborah A. Thomas, MD, Stefan Faderl, MD, Susan O’Brien, MD, Carlos Bueso-Ramos, MD, Jorge Cortes, MD, Guillermo Garcia-Manero, MD, Francis Giles, MD, Srdan Verstovsek, MD, PhD, William Wierda, MD, PhD, Sherry Pierce, RN, Jiaquin Shan, Mark Brandt, Fredrick Hagemeister, MD, Fernando Cabanillas, MD, Michael J. Keating, MD, Hagop Kantarjian, MD

Blood (2005) 106 (11): 149.

https://doi.org/10.1182/blood.V106.11.149.149

Published: 2005

NARROW

MDS and AML in Shwachman-Diamond Syndrome: Clinical Features and Outcomes

Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia

CLL Cell-Derived Exosomes Promote Bone Marrow Fibrosis and Inhibit Normal Hematopoietic Colony Proliferation

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

APcK 110, a novel Inhibitor of Kit, Extends Survival of NOD-SCID Mice in An AML Xenograft Model.

Cross-Talk Between CLL Cells and Endothelial Cells in the Bone Marrow Microenvironment: Role of Signal Transducer and Activator of Transcription (Stat)-3.

Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia.

High T-Cell Lymphoma Breakpoint 1 (TCL1) Levels Are Associated with Lack of Response and Inferior Outcome Following Fludarabine, Cyclophosphamide, Rituximab (FCR) Frontline Therapy in Patients with Chronic Lymphocytic Leukemia (CLL).

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

ZAP-70 Status Does Not Predict Outcome after Nonmyeloablative Allogeneic Stem-Cell Transplantation (NST) in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) That Fails To Respond to Conventional Chemoimmunotherapy.

Detection of Residual p73 DNA Methylation Predicts for Shorter Disease Free and Overall Survival in Patients (pts) with Philadelphia (Ph) Chromosome Negative Acute Lymphocytic Leukemia (ALL) in Remission.

A Biologically Distinctive Subgroup of Acute Myelogenous Leukemia with Characteristic Nuclear Morphology and a High Frequency of FLT3 Mutation.

Epstein-Barr Virus in Patients with Chronic Lymphocytic Leukemia.

Chemo-Immunotherapy with Hyper-CVAD Plus Ritixumab for Adult Burkitt’s and Burkitt’s Type Lymphoma (BL) or Acute Lymphoblastic Leukemia (B-ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only